Northern Pharmacies Limited

POWER SEARCH PRICING

SOLUTIONS

northern pharmacies limited Company Information

Company Number

NI007549

Next Accounts

Dec 2025

Directors

Sarah Mawhinney

Michael Hamill

View All

Shareholders

Group Structure

View All

Industry

Dispensing chemist in specialised stores

Registered Address

5 annadale avenue, belfast, BT7 3JH

Website

www.northernpharmacies.co.uk

northern pharmacies limited Estimated Valuation

£7.8m

Pomanda estimates the enterprise value of NORTHERN PHARMACIES LIMITED at £7.8m based on Net Assets of £3.8m and 2.09x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Northern Pharmacies Limited is a live company located in belfast, BT7 3JH with a Companies House number of NI007549. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in March 1969, it's largest shareholder is unknown. Northern Pharmacies Limited is a mature, mid sized company, Pomanda has estimated its turnover at £5.1m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Northern Pharmacies Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating4out of 5

3 Strong

4 Regular

5 Weak

Size

annual sales of £5.1m, make it smaller than the average company (£12.6m)

Growth

3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (7.4%)

EXPORT

Northern Pharmacies Limited's latest turnover from March 2024 is estimated at £5.1 million and the company has net assets of £3.8 million. According to their latest financial statements, Northern Pharmacies Limited has 47 employees and maintains cash reserves of £523.6 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	5,061,378	3,663,925	3,673,023	3,641,762	3,134,181	2,782,041	2,377,998	2,351,515	1,793,796	2,421,888	2,523,230	3,418,547	2,906,971	3,602,044	3,896,197
Other Income Or Grants
Cost Of Sales	3,478,993	2,470,442	2,461,855	2,511,708	2,186,484	1,916,757	1,609,954	1,595,411	1,241,352	1,690,281	1,747,842	2,379,713	2,058,336	2,533,749	2,711,697
Gross Profit	1,582,385	1,193,482	1,211,169	1,130,054	947,696	865,284	768,044	756,104	552,444	731,607	775,389	1,038,833	848,635	1,068,294	1,184,499
Admin Expenses	1,469,975	1,145,836	1,056,824	763,367	732,792	746,358	558,434	389,517	154,184	299,440	578,122	765,500	612,774	737,445	-683,964
Operating Profit	112,410	47,646	154,345	366,687	214,904	118,926	209,610	366,587	398,260	432,167	197,267	273,333	235,861	330,849	1,868,463
Interest Payable	32,086	63,731	50,905	57,273	72,583	93,271	95,682	47,426
Interest Receivable	39,049	52,069	9,029	829	813	6,084	3,811	2,405	5,153	4,800	4,457	3,495	2,995	2,526	1,050
Pre-Tax Profit	119,373	35,984	112,469	310,243	143,133	31,740	117,740	321,566	403,414	436,967	201,723	276,828	238,855	333,375	1,869,513
Tax	-29,843	-6,837	-21,369	-58,946	-27,195	-6,031	-22,371	-64,313	-80,683	-91,763	-46,396	-66,439	-62,102	-93,345	-523,463
Profit After Tax	89,530	29,147	91,100	251,297	115,938	25,709	95,369	257,253	322,731	345,204	155,327	210,389	176,753	240,030	1,346,049
Dividends Paid
Retained Profit	89,530	29,147	91,100	251,297	115,938	25,709	95,369	257,253	322,731	345,204	155,327	210,389	176,753	240,030	1,346,049
Employee Costs	1,247,564	832,357	707,873	854,013	757,586	819,011	673,190	574,039	278,488	362,892	378,993	471,867	368,492	472,942	486,257
Number Of Employees	47	34	31	41	37	40	35	31	16	21	22	28	22	28	29
EBITDA*	320,845	178,786	306,040	413,857	260,819	167,863	264,013	427,548	466,635	483,589	229,395	307,898	268,880	353,954	1,889,133

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	290,066	184,550	317,201	902,275	861,271	889,276	937,963	990,734	1,051,429	1,111,572	955,079	908,245	933,980	734,616	585,205
Intangible Assets	2,001,189	757,032	855,775	954,519
Investments & Other	232,515	2,805,710	2,819,959	3,162,019	3,039,890	3,034,600	3,164,794	3,065,972	613,488	370,025	47,107	43,608	43,608	43,608	38,344
Debtors (Due After 1 year)	85,740	105,296	115,185
Total Fixed Assets	2,609,510	3,852,588	4,108,120	5,018,813	3,901,161	3,923,876	4,102,757	4,056,706	1,664,917	1,481,597	1,002,186	951,853	977,588	778,224	623,549
Stock & work in progress	313,453	199,535	204,348	216,660	152,858	152,858	156,658	159,457	157,905	164,285	189,764	201,570	201,664	201,482	183,883
Trade Debtors	554,415	446,246	476,619	452,070	412,736	266,133	235,462	306,270	299,788	365,059	390,547	642,366	549,686	621,234	708,634
Group Debtors
Misc Debtors	195,248	128,115	122,704	93,035	76,686	53,240	61,967	85,798	73,783
Cash	523,581	964,011	1,486,294	921,558	736,961	888,342	734,105	790,412	1,133,621	927,749	992,263	790,453	607,400	590,440	419,933
misc current assets	783,598	400,000
total current assets	2,370,295	2,137,907	2,289,965	1,683,323	1,379,241	1,360,573	1,188,192	1,341,937	1,665,097	1,457,093	1,572,574	1,634,389	1,358,750	1,413,156	1,312,450
total assets	4,979,805	5,990,495	6,398,085	6,702,136	5,280,402	5,284,449	5,290,949	5,398,643	3,330,014	2,938,690	2,574,760	2,586,242	2,336,338	2,191,380	1,935,999
Bank overdraft		113,203	113,203	161,296	100,888	93,886	90,872	92,598
Bank loan
Trade Creditors	498,034	337,029	312,621	339,063	293,030	238,011	225,931	231,464	253,659	329,051	408,318	587,014	543,411	581,204	568,221
Group/Directors Accounts		653,795	612,159	556,694	292,544	178,168	59,885
other short term finances
hp & lease commitments
other current liabilities	502,197	392,439	599,496	635,405	238,851	187,652	168,678	282,324	142,304
total current liabilities	1,000,231	1,496,466	1,637,479	1,692,458	925,313	697,717	545,366	606,386	395,963	329,051	408,318	587,014	543,411	581,204	568,221
loans		457,212	559,919	673,887	941,732	1,243,267	1,335,546	1,425,037
hp & lease commitments
Accruals and Deferred Income	160,129	319,176	1,284	1,510	1,777	2,090	2,459	2,893	3,403	4,004	4,710	5,542	6,520
other liabilities			498,085	637,765	40,000	90,000	150,000	220,000
provisions	67,619	55,345	68,169	154,467	80,828	76,561	108,473	90,591	134,165	131,883	33,184	20,465	23,575	16,427	12,705
total long term liabilities	227,748	831,733	1,127,457	1,467,629	1,064,337	1,411,918	1,596,478	1,738,521	137,568	135,887	37,894	26,007	30,095	16,427	12,705
total liabilities	1,227,979	2,328,199	2,764,936	3,160,087	1,989,650	2,109,635	2,141,844	2,344,907	533,531	464,938	446,212	613,021	573,506	597,631	580,926
net assets	3,751,826	3,662,296	3,633,149	3,542,049	3,290,752	3,174,814	3,149,105	3,053,736	2,796,483	2,473,752	2,128,548	1,973,221	1,762,832	1,593,749	1,355,073
total shareholders funds	3,751,826	3,662,296	3,633,149	3,542,049	3,290,752	3,174,814	3,149,105	3,053,736	2,796,483	2,473,752	2,128,548	1,973,221	1,762,832	1,593,749	1,355,073

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	112,410	47,646	154,345	366,687	214,904	118,926	209,610	366,587	398,260	432,167	197,267	273,333	235,861	330,849	1,868,463
Depreciation	39,013	32,397	52,951	47,170	45,915	48,937	54,403	60,961	68,375	51,422	32,128	34,565	33,019	23,105	20,670
Amortisation	169,422	98,743	98,744
Tax	-29,843	-6,837	-21,369	-58,946	-27,195	-6,031	-22,371	-64,313	-80,683	-91,763	-46,396	-66,439	-62,102	-93,345	-523,463
Stock	113,918	-4,813	-12,312	63,802		-3,800	-2,799	1,552	-6,380	-25,479	-11,806	-94	182	17,599	183,883
Debtors	155,746	-34,851	169,403	55,683	170,049	21,944	-94,639	18,497	8,512	-25,488	-251,819	92,680	-71,548	-87,400	708,634
Creditors	161,005	24,408	-26,442	46,033	55,019	12,080	-5,533	-22,195	-75,392	-79,267	-178,696	43,603	-37,793	12,983	568,221
Accruals and Deferred Income	-49,289	110,835	-36,135	396,287	50,886	18,605	-114,080	139,510	141,703	-706	-832	-978	6,520
Deferred Taxes & Provisions	12,274	-12,824	-86,298	73,639	4,267	-31,912	17,882	-43,574	2,282	98,699	12,719	-3,110	7,148	3,722	12,705
Cash flow from operations	145,328	334,032	-21,295	751,385	173,747	142,461	237,349	416,927	452,413	461,519	279,815	188,388	254,019	347,115	1,054,079
Investing Activities
capital expenditure	-1,558,108	100,254	532,123	-1,042,693	-17,910	-250	-1,632	-266	-8,232	-207,915	-78,962	-8,830	-232,383	-172,516	-605,875
Change in Investments	-2,573,195	-14,249	-342,060	122,129	5,290	-130,194	98,822	2,452,484	243,463	322,918	3,499			5,264	38,344
cash flow from investments	1,015,087	114,503	874,183	-1,164,822	-23,200	129,944	-100,454	-2,452,750	-251,695	-530,833	-82,461	-8,830	-232,383	-177,780	-644,219
Financing Activities
Bank loans
Group/Directors Accounts	-653,795	41,636	55,465	264,150	114,376	118,283	59,885
Other Short Term Loans
Long term loans	-457,212	-102,707	-113,968	-267,845	-301,535	-92,279	-89,491	1,425,037
Hire Purchase and Lease Commitments
other long term liabilities		-498,085	-139,680	597,765	-50,000	-60,000	-70,000	220,000
share issue													-7,670	-1,354	9,024
interest	6,963	-11,662	-41,876	-56,444	-71,770	-87,187	-91,871	-45,021	5,153	4,800	4,457	3,495	2,995	2,526	1,050
cash flow from financing	-1,104,044	-570,818	-240,059	537,626	-308,929	-121,183	-191,477	1,600,016	5,153	4,800	4,457	3,495	-4,675	1,172	10,074
cash and cash equivalents
cash	-440,430	-522,283	564,736	184,597	-151,381	154,237	-56,307	-343,209	205,872	-64,514	201,810	183,053	16,960	170,507	419,933
overdraft	-113,203		-48,093	60,408	7,002	3,014	-1,726	92,598
change in cash	-327,227	-522,283	612,829	124,189	-158,383	151,223	-54,581	-435,807	205,872	-64,514	201,810	183,053	16,960	170,507	419,933

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for northern pharmacies limited. Get real-time insights into northern pharmacies limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for northern pharmacies limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in BT7 area or any other competitors across 12 key performance metrics.

NORTHERN PHARMACIES LIMITED group structure

Northern Pharmacies Limited has 1 subsidiary company.

Ultimate parent company

NORTHERN PHARMACIES LIMITED

NI007549

1 subsidiary

SWEENEY'S PHARMACIES LIMITED

NI003054

NORTHERN PHARMACIES LIMITED Shareholders

Northern Pharmacies Limited currently has 8 directors. The longest serving directors include Mrs Sarah Mawhinney (Mar 2000) and Mr Michael Hamill (Jun 2010).

officer	country	age	start	end	role
Mrs Sarah Mawhinney		69 years	Mar 2000	-	Director
Mr Michael Hamill		45 years	Jun 2010	-	Director
Mr Paul Kelly	Northern Ireland	82 years	Jan 2013	-	Director
Dr Martin Kerr		67 years	Apr 2013	-	Director
Dr Terence Maguire		66 years	Jun 2015	-	Director
Mr Stephen Slaine		60 years	Jan 2023	-	Director
Mrs Edel Etherson		40 years	Jan 2023	-	Director
Mr John Anderson		69 years	Sep 2023	-	Director

P&L

March 2024

turnover

5.1m

+38%

operating profit

112.4k

gross margin

31.3%

-4.02%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

3.8m

+0.02%

total assets

-0.17%

cash

523.6k

-0.46%

net assets

Total assets minus all liabilities

Similar Companies

coagh pharmacies limited

3.5

2.5

company number

NI007549

Type

Private Ltd By Guarantee w/o Share Cap

industry

47730 - Dispensing chemist in specialised stores

incorporation date

March 1969

ultimate parent company

None

previous names

N/A

address

5 annadale avenue, belfast, BT7 3JH

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to northern pharmacies limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for NORTHERN PHARMACIES LIMITED. This can take several minutes, an email will notify you when this has completed.

northern pharmacies limited Company Information

northern pharmacies limited Estimated Valuation

northern pharmacies limited Estimated Valuation

northern pharmacies limited Estimated Valuation

Northern Pharmacies Limited Overview

Northern Pharmacies Limited Health Check

NORTHERN PHARMACIES LIMITED financials

northern pharmacies limited Credit Report and Business Information

Northern Pharmacies Limited Competitor Analysis

northern pharmacies limited Ownership

northern pharmacies limited directors

northern pharmacies limited company details

northern pharmacies limited Charges & Mortgages

northern pharmacies limited Capital Raised & Share Issues BETA

northern pharmacies limited Companies House Filings - See Documents